Geron stem cell trial for spinal cord injury gets FDA approval
Geron Corp. said Friday it was notified by the U.S. Food and Drug Administration that a clinical hold placed on the company’s Investigational New Drug application has been lifted and the clinical trial of …
[Read the full article here]Related News:
Geron To Proceed With First Human Clinical Trial Of Embryonic Stem Cell-Based Therapy
FDA Approves Embryonic Stem Cell-Based Therapy For Patients With Acute Spinal Cord Injury
Neuralstem Files IND Application With FDA To Begin Spinal Cord Injury Stem Cell Trial …